← IDEAYA Biosciences, Inc.
| Annual Trend | FY 2011 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $23.8m |
$0
-100.00%
|
$2.1m |
$2.3m
+10.86%
|
$19.5m
+750.96%
|
$27.9m
+43.01%
|
$50.9m
+82.28%
|
$23.4m
-54.08%
|
$7.0m
-70.07%
|
$218.7m
+3024.43%
|
$234.1m
+7.05%
|
|
| Research and development | — | $12.4m | $31.7m | $34.3m | $39.7m | $58.2m | $89.5m | $129.5m | $294.7m | $314.7m | $374.0m | |
| General and administrative | ($4.5m) | $2.1m | $4.7m | $10.0m | $15.2m | $20.1m | $23.9m | $28.3m | $39.3m | $63.3m | $77.1m | |
| Operating Lease, Expense | — | — | — | $1.5m | $1.5m | $1.7m | $1.7m | — | — | — | — | |
| Operating Expenses | — | $14.4m | $36.4m | $44.3m | $54.9m | $78.2m | $113.4m | $157.8m | $334.0m | $378.0m | $451.1m | |
| Loss from operations | $1.7m |
($14.4m)
-930.34%
|
($36.4m)
-152.23%
|
($44.3m)
-21.57%
|
($35.3m)
+20.16%
|
($50.3m)
-42.22%
|
($62.5m)
-24.34%
|
($134.4m)
-115.08%
|
($327.0m)
-143.23%
|
($159.3m)
+51.28%
|
— | |
| Operating Income (Loss) | $1.7m |
($14.4m)
-930.34%
|
($36.4m)
-152.23%
|
($44.3m)
-21.57%
|
($35.3m)
+20.16%
|
($50.3m)
-42.22%
|
($62.5m)
-24.34%
|
($134.4m)
-115.08%
|
($327.0m)
-143.23%
|
($159.3m)
+51.28%
|
($217.0m)
-36.18%
|
|
| Interest income and other income, net | — | — | $2.1m | $2.3m | $849k | $506k | $3.8m | $21.5m | $52.5m | $45.6m | $41.9m | |
| Other Nonoperating Income (Expense) | — | — | $77k | $8k | — | — | — | — | — | — | — | |
| Pre-Tax Income | ($3.1m) | ($11.9m) | ($34.3m) | ($42.0m) | ($34.5m) | ($49.8m) | ($58.7m) | ($113.0m) | ($274.5m) | ($113.7m) | ($175.0m) | |
| Income Tax Expense (Benefit) | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Net loss | ($3.1m) | ($11.9m) | ($34.3m) | ($42.0m) | ($34.5m) | ($49.8m) | ($58.7m) | ($113.0m) | ($274.5m) | ($113.7m) | — | |
| Net Income From Continuing And Discontinued Operation | ($3.1m) | ($11.9m) | ($34.3m) | ($42.0m) | ($34.5m) | ($49.8m) | ($58.7m) | ($113.0m) | ($274.5m) | ($113.7m) | ($175.0m) | |
| Otherunder Preferred Stock Dividend | — | — | — | — | — | $719k | $2.2m | — | — | — | — | |
| Earnings Per Share, Basic | ($0.24) | — | — | — | — | — | ($1.42) | ($1.96) | ($3.36) | ($1.28) | ($1.92) | |
| Earnings Per Share, Diluted | ($0.24) | — | — | — | — | — | ($1.42) | ($1.96) | ($3.36) | ($1.28) | ($1.92) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | — | 41.4m | 57.5m | 81.7m | 88.5m | 89.5m | |
| Basic Average Shares | — | — | — | — | — | — | $41.4m | $57.5m | $81.7m | $88.5m | $89.5m | |
| Diluted Average Shares | — | — | — | — | — | — | $41.4m | $57.5m | $81.7m | $88.5m | $89.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | — | 41.4m | 57.5m | 81.7m | 88.5m | 89.5m | |
| Additional Financial Items | ||||||||||||
| Unrealized gains on marketable securities | — | ($1k) | ($30k) | $96k | ($58k) | ($719k) | ($2.2m) | $3.4m | $250k | $1.5m | — | |
| Comprehensive loss | — | ($11.9m) | ($34.4m) | ($41.9m) | ($34.6m) | ($50.5m) | ($60.8m) | ($109.5m) | ($274.2m) | ($112.2m) | — | |
| Depreciation and amortization | ($81k) | — | — | — | — | — | — | — | — | — | — | |
| Diluted EPS | ($0.24) | — | — | — | — | — | ($1.42) | ($1.96) | ($3.36) | ($1.28) | ($1.92) | |
| Diluted NI Availto Com Stockholders | ($3.1m) | ($11.9m) | ($34.3m) | ($42.0m) | ($34.5m) | ($49.8m) | ($58.7m) | ($113.0m) | ($274.5m) | ($113.7m) | ($175.0m) | |
| Normalized EBITDA | — | — | — | — | — | — | ($59.0m) | ($130.4m) | ($323.1m) | ($154.7m) | ($212.5m) | |
| Normalized Income | ($3.1m) | ($11.9m) | ($34.3m) | ($42.0m) | ($34.5m) | ($49.8m) | ($58.7m) | ($113.0m) | ($274.5m) | ($113.7m) | ($175.0m) | |
| Other Gand A | ($4.5m) | $2.1m | $4.7m | $10.0m | $15.2m | $20.1m | $23.9m | $28.3m | $39.3m | $63.3m | — | |
| Reconciled Depreciation | — | — | — | — | — | — | $3.5m | $4.0m | $3.8m | $4.6m | $4.5m | |
| Selling General And Administration | ($4.5m) | $2.1m | $4.7m | $10.0m | $15.2m | $20.1m | $23.9m | $28.3m | $39.3m | $63.3m | — | |
| Tax Effect Of Unusual Items | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Tax Rate For Calcs | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Total Expenses | — | $14.4m | $36.4m | $44.3m | $54.9m | $78.2m | $113.4m | $157.8m | $334.0m | $378.0m | $451.1m |